P Liebisch, S Eppinger, C Schopflin, G Stehle, G Munzert, H Dohner, M Schmid. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q. haematol [Internet]. 2005Apr.1 [cited 2024Nov.26];90(4):489-93. Available from: https://haematologica.org/article/view/3479